Company Overview

Update
Founded:
February 1, 2012
Headquarters:
Jena
Funding:
$0
Categories:
Biotechnology

oncgnostics develops IVD tests for screening, therapeutic decision making, and follow-up care in cancer diagnostics.

Description

Update

oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer diagnostics.

The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These marker regions are detected using well-established PCR-based technologies, which can be performed in routine molecular diagnostics laboratories with standard equipment. oncgnostics has identified novel markers for detecting cervical precancerous lesions and carcinomas.

Funding Rounds (1) - $0

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    BioInstrumentezentrum Jena

    Winzelaer Str. 2

    Jena, 07745

    DEU

Images (1)

Update
  • 059303135e2c45a889e1014a88ef97ab